AFIB
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
22.3M
GET INTRADAY SIGNALS
AFIB Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
45 days until earnings call
+Compare
AFIB
Stock ticker:
NASDAQ
AS OF
Loading...
Price
Loading...
Change
Loading...
Capitalization
22.3M

AFIB Price Prediction, Acutus Medical AI Recommendations

Stock market charts, price targets, analyst ratings and a financial calendar

GET INTRADAY SIGNALS
AFIB Trading results, last 6 months
AI Robots NameP/LEntry Price, $Profit, $/%
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
a Summary for AAPL with price predictions
12:00 AM EDT Mar 24, 2023

Momentum Indicator for AFIB turns negative, indicating new downward trend

AFIB saw its Momentum Indicator move below the 0 level on March 01, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 42 similar instances where the indicator turned negative. In 38 of the 42 cases, the stock moved further down in the following days. The odds of a decline are at 90%.

Price Prediction Chart

Technical Analysis (Indicators)

Bearish Trend Analysis

AFIB moved below its 50-day moving average on March 02, 2023 date and that indicates a change from an upward trend to a downward trend.

The 10-day moving average for AFIB crossed bearishly below the 50-day moving average on March 06, 2023. This indicates that the trend has shifted lower and could be considered a sell signal. In of 3 past instances when the 10-day crossed below the 50-day, the stock continued to move higher over the following month. The odds of a continued downward trend are .

Following a 3-day decline, the stock is projected to fall further. Considering past instances where AFIB declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .

The Aroon Indicator for AFIB entered a downward trend on March 24, 2023. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Bullish Trend Analysis

The RSI Indicator shows that the ticker has stayed in the oversold zone for 4 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an Uptrend is expected.

The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 16 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.

Following a +1 3-day Advance, the price is estimated to grow further. Considering data from situations where AFIB advanced for three days, in of 117 cases, the price rose further within the following month. The odds of a continued upward trend are .

AFIB may jump back above the lower band and head toward the middle band. Traders may consider buying the stock or exploring call options.

Fundamental Analysis (Ratings)

Fear & Greed

The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is fair valued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (0.297) is normal, around the industry mean (16.030). P/E Ratio (4.488) is within average values for comparable stocks, (182.763). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (5.813). Dividend Yield (0.000) settles around the average of (0.019) among similar stocks. P/S Ratio (1.352) is also within normal values, averaging (58.750).

The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.

The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating slightly worse than average price growth. AFIB’s price grows at a lower rate over the last 12 months as compared to S&P 500 index constituents.

The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating weak sales and an unprofitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.

The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating that the returns do not compensate for the risks. AFIB’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 85, placing this stock worse than average.

AI
A.I. Advisor
published Earnings

AFIB is expected to report earnings to rise 4.76% to -66 cents per share on May 11

Acutus Medical AFIB Stock Earnings Reports
Q1'23
Est.
$-0.66
Q4'22
Beat
by $0.05
Q3'22
Beat
by $0.09
Q2'22
Missed
by $0.13
Q1'22
Missed
by $0.10
The last earnings report on March 16 showed earnings per share of -62 cents, beating the estimate of -68 cents. With 58.40K shares outstanding, the current market capitalization sits at 22.30M.
AI
A.I.Advisor
published Highlights

Notable companies

The most notable companies in this group are Abbott Laboratories (NYSE:ABT), Medtronic plc (NYSE:MDT), Intuitive Surgical (NASDAQ:ISRG), Boston Scientific Corp (NYSE:BSX), Edwards Lifesciences Corp (NYSE:EW), IQVIA Holdings (NYSE:IQV), Illumina (NASDAQ:ILMN), Align Technology (NASDAQ:ALGN), Exact Sciences Corp (NASDAQ:EXAS), Guardant Health (NASDAQ:GH).

Industry description

Medical specialties are companies that make equipment used by the health care industry. Equipment manufactured and distributed by these companies include dialysis machines, blood analysis equipment, surgical equipment, dental instruments, and diagnostic tools, among other items. Large companies typically aim to produce and distribute high-quality products across a broad market spectrum. Smaller firms are more likely to specialize in a particular market segment. Due to the industry’s close association with medical treatments, they typically have low sensitivity to macroeconomic fluctuations. Within this industry, Abbott Laboratories, Medtronic Plc and Thermo Fisher Scientific Inc. are some of the companies with multi-billion market capitalizations in the U.S. stock markets.

Market Cap

The average market capitalization across the Medical Specialties Industry is 6.29B. The market cap for tickers in the group ranges from 27 to 3.82T. MKYSF holds the highest valuation in this group at 3.82T. The lowest valued company is FOGCF at 27.

High and low price notable news

The average weekly price growth across all stocks in the Medical Specialties Industry was 0%. For the same Industry, the average monthly price growth was -5%, and the average quarterly price growth was 8%. ECOR experienced the highest price growth at 62%, while AZYO experienced the biggest fall at -62%.

Volume

The average weekly volume growth across all stocks in the Medical Specialties Industry was -51%. For the same stocks of the Industry, the average monthly volume growth was -26% and the average quarterly volume growth was -94%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 50
P/E Growth Rating: 69
Price Growth Rating: 62
SMR Rating: 82
Profit Risk Rating: 85
Seasonality Score: 5 (-100 ... +100)
AI
View a ticker or compare two or three
Technical Analysis# Of IndicatorsAvg. Odds
   
   
Show details...
AI
A.I.Advisor
published price charts
AI
A.I. Advisor
published General Information

General Information

a company, which engages in the development of medical devices and electrophy equipment

Industry MedicalSpecialties

Profile
Fundamentals
Details
Industry
N/A
Address
2210 Faraday Avenue
Phone
+1 442 232-6080
Employees
338
Web
https://www.acutusmedical.com
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
GPC156.882.59
+1.68%
Genuine Parts Company
AEL35.320.34
+0.97%
American Equity Investment Life Holding Company
SCHN29.340.12
+0.41%
Schnitzer Steel Industries
FULC3.150.01
+0.32%
Fulcrum Therapeutics
WTER0.14N/A
-0.55%
Alkaline Water Company (The)

AFIB and

Correlation & Price change

A.I.dvisor tells us that AFIB and VRAY have been poorly correlated (+27% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that AFIB and VRAY's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To AFIB
1D Price
Change %
AFIB100%
-3.56%
VRAY - AFIB
27%
Poorly correlated
N/A
BRKR - AFIB
25%
Poorly correlated
+1.23%
WAT - AFIB
24%
Poorly correlated
+0.60%
MTD - AFIB
24%
Poorly correlated
+0.60%
A - AFIB
24%
Poorly correlated
+0.63%
More